Skip to main content

Table 1 Recent development of drug delivery systems for liver fibrosis therapy

From: Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy

Nanocarriers Targeted molecules Drugs Reference
liposomes Vitamin A Imatinib [10] (2017)
PLGA-PSPE-PEG NPs Vitamin A Silibinin & siCol1α1 [12] (2018)
CaP@BSA NPs / TSG-6 [35] (2020)
HA nanomicelles Hyaluronic acid Silibinin [36] (2019)
PEG-PLGA NPs Vitamin A Nilotinib [37] (2019)
CS nanomicelles Chondroitin sulfate Doxorubicin & retinoic acid [38] (2019)
Lipid nanoparticles Vitamin A siCol1α1 & siTIMP-1 [39] (2020)
Liposomes cRGDyK Vismodegib [40] (2019)
Polymeric micelles / Polydatin [41] (2020)